RARE · Ultragenyx Pharmaceutical Inc.

Summary

Ultragenyx Pharmaceutical Inc. issued a press release on March 12, 2026, announcing positive results from its Phase 3 Enh3ance study. This disclosure under Item 8.01 represents a significant clinical milestone for the Company.

Key takeaways

• Ultragenyx issued press release on 2026-03-12
• Announced positive results from Phase 3 Enh3ance study